• SE Asia (HQ)

    +65 3158 9940

  • Australia

    1300 798 820

  • New Zealand

    +64 9801 0299

September 2018 - ICLUSIG® achieves extended PBS listing

ST achieves further PBS reimbursement for ICLUSIG® in PH+ Acute Lymphoblastic Leukaemia (ALL)